Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Nov;42(11):3427-3437.
doi: 10.1002/hed.26428. Epub 2020 Sep 23.

Utility of narrowband imaging in the diagnosis of laryngeal leukoplakia: Systematic review and meta-analysis

Affiliations
Meta-Analysis

Utility of narrowband imaging in the diagnosis of laryngeal leukoplakia: Systematic review and meta-analysis

Sejad Ahmadzada et al. Head Neck. 2020 Nov.

Abstract

This systematic review and meta-analysis evaluates the validity of narrowband imaging (NBI) in differentiating between low-risk leukoplakia and high-risk leukoplakia. Medline, EMBASE, Scopus, Cochrane Database of Systematic Reviews and Database of Abstracts of Reviews of Effects were searched. Studies evaluating the diagnostic accuracy of NBI in the assessment of laryngeal leukoplakia were included. Pooled sensitivity, specificity and diagnostic odds ratio were calculated. Seven studies met the inclusion criteria assessing a total of 586 lesions with laryngeal leukoplakia. In differentiating between low-risk and high-risk leukoplakia, NBI had a pooled sensitivity and specificity of 85.4% (95% CI [76-99.9]) and 94.9% (95% CI [91.1-97.2]) respectively. Pooled diagnostic odds ratio was 99.2 (95% CI [38.28-257.18]). NBI is a useful imaging modality in differentiating between low-risk leukoplakia and high-risk laryngeal leukoplakia. The high sensitivity, specificity and diagnostic odds ratio make NBI a useful tool in the workup of laryngeal leukoplakia.

Keywords: Ni classification; laryngeal cancer; leukoplakia; narrowband imaging.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Isenberg JS, Crozier DL, Dailey SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol. 2008;117:74-79.
    1. Ni X-G, Zhu J-Q, Zhang Q-Q, Zhang B-G, Wang G-Q. Diagnosis of vocal cord leukoplakia: the role of a novel narrow band imaging endoscopic classification. Laryngoscope. 2019;129:429-434.
    1. AIHW. Head and Neck Cancers in Australia: Cancer Series. Australia: Australian Institute of Health and Welfare; 2014.
    1. Groome PA, O'Sullivan B, Irish JC, et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the surveillance, epidemiology, and end results areas of the United States. J Clin Oncol. 2003;21:496-505.
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.

LinkOut - more resources